{
    "id": 23024,
    "fullName": "KIT W557C",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KIT W557C lies within the juxtamembrane domain (exon 11) of the Kit protein (PMID: 16226710). W557C has been identified in the scientific literature (PMID: 28327988) but has not been biochemically characterized and therefore, its effect on Kit protein function is unknown (PubMed, Nov 2019).",
            "references": [
                {
                    "id": 9177,
                    "pubMedId": 28327988,
                    "title": "Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28327988"
                },
                {
                    "id": 648,
                    "pubMedId": 16226710,
                    "title": "Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16226710"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3815,
        "geneSymbol": "KIT",
        "terms": [
            "KIT",
            "C-Kit",
            "CD117",
            "MASTC",
            "PBT",
            "SCFR"
        ]
    },
    "variant": "W557C",
    "createDate": "06/08/2016",
    "updateDate": "11/15/2019",
    "referenceTranscriptCoordinates": {
        "id": 136898,
        "transcript": "NM_000222",
        "gDna": "chr4:g.54727439G>T",
        "cDna": "c.1671G>T",
        "protein": "p.W557C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6808,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a GIST patient harboring KIT K558_V560del and KIT W557C, resistant to Gleevec (imatinib), Sutent (sunitinib), and Stivarga (regorafenib), demonstrated sensitivity when treated with Iclusig (ponatinib), which resulted in a radiologic response and stabilization for six months (PMID: 25239608).",
            "molecularProfile": {
                "id": 23705,
                "profileName": "KIT W557C KIT K558_V560del"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 9253,
                "name": "gastrointestinal stromal tumor",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 3860,
                    "pubMedId": 25239608,
                    "title": "Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25239608"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6880,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib mesylate) inhibited Kit phosphorylation efficiently in transformed human cells over expressing both KIT W557C and KIT Y578C in culture (PMID: 23567324).",
            "molecularProfile": {
                "id": 23934,
                "profileName": "KIT W557C KIT Y578C"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 647,
                    "pubMedId": 23567324,
                    "title": "Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23567324"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23703,
            "profileName": "KIT W557C",
            "profileTreatmentApproaches": [
                {
                    "id": 8967,
                    "name": "KIT Inhibitor",
                    "profileName": "KIT W557C"
                }
            ]
        },
        {
            "id": 23705,
            "profileName": "KIT W557C KIT K558_V560del",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 23934,
            "profileName": "KIT W557C KIT Y578C",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 136899,
            "transcript": "XM_017008178",
            "gDna": "chr4:g.54727439G>T",
            "cDna": "c.1671G>T",
            "protein": "p.W557C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136898,
            "transcript": "NM_000222",
            "gDna": "chr4:g.54727439G>T",
            "cDna": "c.1671G>T",
            "protein": "p.W557C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}